Home›Companies›Biotech & Pharma›Proxima

Proxima Bio, Inc.

Develops AI drug discovery tools and medicines for pharmaceutical research.

Updated Nov 10, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About Proxima

Proxima is a private company based in New York, New York. It has reported $91,454,999 raised in one offering on Form D since January 2026. Its chief executive is Zachary Carpenter.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 12, 2026Jan 21, 2026amended Jun 10, 2026$91,454,999fully sold11$8.3MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Proxima's Form D filed Jun 10, 2026.

Zachary Carpenter
Zachary Carpenter
Co-founder & CEO, director
JM
John McFarland
Secretary and CFO

Sources

  1. SECProxima Bio, Inc. Form D, filed Jan 21, 2026
  2. SECProxima Bio, Inc. filing history
  3. CompanyProxima contact
  4. CompanyProxima team